ScottR.SchellMDPhD MBA FACS

Summary

• Scott Schell, PhD, MD, MBA is a healthcare futurist and precision medicine expert. His clinical experience is in surgical oncology, with basic-science research expertise in immunology and molecular genetics. A serial entrepreneur with 5 successful startups, and collaboration with dozens of other pharma, biomedical, device, and health tech companies. In addition to serving part-time as a Managing Partner and CMO in a private equity firm, he currently has a global consulting portfolio in population health, precision medicine, and application of AI to chronic and complex disease management

Clio Health GO Pass - COVID symptom tracking with AI predictives
We released prototype versions of GO Pass in March. Anonymous population predictives without any personal data loss.

UPMC -$120M, 4 year project
Leading Population Health and RevCycle management at UPMC's health plan, ambulatory, and hospital practices

Scott Schell, PHD MD MBA - Molecular Diagnostics Company CEO
A great story on how to turn around a company

Health Futurist Technology now
Immediately before the pandemic, "old-school" physicians in the audience tutted this was "impossible". Clio Health is live and well.

Reinventing the health technology incubator
We've shortened time-to-market and reduced costs by 6-fold. How? We've created a partnership between Penn Medicine, a Blue Cross franchise, and a PE firm.